Results 111 to 120 of about 24,574 (253)

Effects of highly active antiretroviral therapy (HAART) on platelet activating factor (PAF) metabolism in HIV-infected patients: in vivo results [PDF]

, 2008
AB Tsoupras, Maria Chini, Nikos Tsogas, Nikos Mangafas, George Stamatakis, Smaragdi Antonopoulou, CA Demopoulos, M-C Lazanas   +7 more
openalex   +1 more source

Tin(II) and Tin(IV) Complexes Incorporating the Oxygen Tripodal Ligands [(η⁵-C₅R₅)Co{P(OEt)₂O}₃]^-, (R = H, Me; Et = -C₂H₅) as Potent Inflammatory Mediator Inhibitors: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin. [PDF]

Molecules, 2023
Kalampalidis A, Damati A, Matthopoulos D, Tsoupras AB, Demopoulos CA, Schnakenburg G, Philippopoulos AI.   +6 more
europepmc   +1 more source

Plasma lipoproteins inactivate platelet-activating factor (PAF).

Blood & Vessel, 1987
Inactivation of platelet-activating factor (PAF) by plasma was demonstrated by comparing platelet aggregation induced by PAF solution, which had been preincubated with plasma, with that induced by the control PAF solution preincubated with buffer. Plasma inactivated PAF in a volume-dependent manner while preincubation of ADP or collagen with plasma did
Kei SATOH, Shigeru TAKAMATSU, Yoko KAWAMURA, Seitoku MIZUNO, Mutsu TAKAMATSU   +4 more
openaire   +2 more sources

Effect of Platelet-Activating Factor on Barrier Function of ARPE-19 Cells

Drug Design, Development and Therapy, 2020
Fan Zhang,1 Lei Liu,2 Han Zhang,2 Zhe-Li Liu2 1Department of Ophthalmology, The Fourth Affiliated Hospital of China Medical University, Eye Hospital of China Medical University, Key Lens Research Laboratory of Liaoning Province, Shenyang, Liaoning ...
Zhang F, Liu L, Zhang H, Liu ZL
doaj  

A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties?

Bioinorganic Chemistry and Applications, 2017
In this minireview, we refer to recent results as far as the Platelet Activating Factor (PAF) inhibitors are concerned. At first, results of organic compounds (natural and synthetic ones and specific and nonspecific) as inhibitors of PAF are reported ...
Vasiliki D. Papakonstantinou, Nefeli Lagopati, Effie C. Tsilibary, Constantinos A. Demopoulos, Athanassios I. Philippopoulos   +4 more
doaj   +1 more source

Interplay Between EGFR and the Platelet-Activating Factor/PAF Receptor Signaling Axis Mediates Aggressive Behavior of Cervical Cancer. [PDF]

Front Oncol, 2020
Souza JL, Martins-Cardoso K, Guimarães IS, de Melo AC, Lopes AH, Monteiro RQ, Almeida VH.   +6 more
europepmc   +1 more source

Ultraviolet B radiation mediated generation of Platelet-activating factor agonists augments melanoma tumor growth [PDF]

, 2011
poster abstractPlatelet-activating factor (1-alkyl-2-acetyl-glycerophosphocholine; PAF) is a potent lipid mediator with diverse activities. Our previous studies have demonstrated that oxidized glycerophosphocholines (OxGPCs) that act as agonists for the
DaSilva, S.C., Konger, R.L., Sahu, R.P., Touloukian, C.S., Travers, J.B.   +4 more
core  

Platelet-activating factor (PAF) receptor expression is associated with histopathological stage and grade and patients’ survival in gastric adenocarcinoma

, 2014
Constantinos Giaginis, Athina Giagini, Nikolaοs Goutas, E. Patsouris, Gregory Kouraklis, Stamatios Theocharis   +5 more
openalex   +2 more sources

CALCIUM/CALMODULIN-DEPENDENT KINASE II IS REQUIRED FOR PLATELET ACTIVATING FACTOR (PAF) PRIMING OF INFLAMMATORY CELLS. [PDF]

, 2002
Joseph Cuschieri, David M. Gourlay, Eileen M. Bulger, Iris Garcia, Srdjan Jelačić, Ronald V. Maier   +5 more
openalex   +1 more source

Regional Neonatal Associates for cooperative study of platelet-activating factor (PAF). Summary report

, 1992
Fred Snyder
openalex   +2 more sources